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Abstract
Sepsis involves a systemic inflammatory response of multiple endogenous mediators, resulting in many of the injurious and 
sometimes fatal physiological symptoms of the disease. This systemic activation leads to a compromised vascular response 
and endothelial dysfunction. Purine nucleotides interact with purinoceptors and initiate a variety of physiological processes that 
play an important role in maintaining cardiovascular function. The purpose of the present study was to investigate the effects 
of ATP on vascular function in a lipopolysaccharide (LPS) model of sepsis. LPS induced a significant increase in aortic super-
oxide production 16 h after injection. Addition of ATP to the organ bath incubation solution reduced superoxide production by 
the aortas of endotoxemic animals. Reactive Blue, an antagonist of the P2Y receptor, blocked the effect of ATP on superoxide 
production, and the nonselective P2Y agonist MeSATP inhibited superoxide production. Nitric oxide synthase (NOS) inhibi-
tion by L-NAME blocked vascular relaxation and reduced superoxide production in LPS-treated animals. In the presence of 
L-NAME there was no ATP effect on superoxide production. A vascular reactivity study showed that ATP increased maximal 
relaxation in LPS-treated animals compared to controls. The presence of ATP induced increases in Akt and endothelial NOS 
phosphorylated proteins in the aorta of septic animals. ATP reduces superoxide release resulting in an improved vasorelax-
ant response. Sepsis may uncouple NOS to produce superoxide. We showed that ATP through Akt pathway phosphorylated 
endothelial NOS and “re-couples” NOS function.
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Sepsis is one of the main causes of death in non-
coronary intensive care units and, despite advances in the 
understanding of its pathophysiology, epidemiology, and 
treatment, the mortality rate remains high (1). A systemic 
inflammatory response involving multiple endogenous me-
diators is deflagrated, causing tissues and organ damage 
(2). The systemic release of free radicals leads to a compro-
mised vascular response and endothelial dysfunction (3). 
Vascular dysfunction characterized by compromised 
vasoconstriction and vasodilatation functions aggravates 
organ perfusion, leading to a vicious cycle of more tissue 
damage. Endothelial dysfunction in vascular disease states 
is associated with reduced nitric oxide (NO) bioactivity. En-
dothelial NO synthase (eNOS) uncoupling, whereby eNOS 
generates O2•– rather than NO, is a mechanism underlying 
endothelial dysfunction (4). Brandes et al. (5) reported in-
creased production of superoxide and hydrogen peroxide by 
vascular rings of rats treated with lipopolysaccharide (LPS), 
mainly by endothelial cells. Javesghani et al. (6) recently 
reported in addition an increase in peroxynitrite generation 
after LPS injection. These data suggest that some of the 
toxic effects of superoxide in sepsis may actually be caused 
by peroxynitrite (7). In addition, sepsis induces endothelial 
activation (8) with release of ATP and ADP from platelets 
and vasculature (9). ATP and ADP are released by cell 
lysis, selective permeabilization of the plasma membrane 
and secretion from platelet dense bodies in response to 
specific mediators (10-13). Purine nucleotides have the 
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potential to modulate endothelial cells, platelet activation, 
leukocyte migration, and cytokine release (14). NO has 
been reported to regulate the mitochondrial respiratory 
cascade and to increase superoxide production with a lower 
production of ATP, an important event in sepsis (15,16). At 
the same time, oxidative stress activates poly(ADP-ribose) 
polymerase that consumes ATP (17). ATP has been reported 
to modulate the vascular release of NO under physiological 
conditions (18) and to modulate the release of superoxide 
in macrophages (19,20) as well as inflammatory mediators 
by the autonomic system (21).
The effect of ATP on vascular and endothelial function 
in sepsis has not been studied. We present data showing 
that ATP increased vascular relaxation in septic rings, an 
important fact from a clinical viewpoint. Therefore, we 
hypothesized that ATP is able to repair endothelial dys-
function. In order to attempt to understand this process, 
we determined the actions of ATP on vascular function 
during sepsis in terms of vascular reactivity and their cor-
relation with superoxide and NO production and eNOS 
phosphorylation.
Material and Methods
The Ethics Committee for Analysis of Research Projects 
(CAPPesq) approved the present in vivo study, which was 
conducted according to CAPPesq guidelines and according 
to the Guide for the Care and Use of Laboratory Animals 
adopted and promulgated by the U.S. National Institutes 
of Health.
Experimental protocol
Forty male Wistar rats weighing 240-260 g were ran-
domly assigned to 2 groups: one group received 10 mg/kg, 
ip, LPS (Escherichia coli serotype 026:B6) and the other 
received saline ip. Animals were sacrificed 16 h after LPS 
or vehicle injection. 
Aorta preparation
The aorta preparation was the same for the experi-
ments of vascular superoxide generation and vascular 
reactivity. The thoracic aortas were harvested, cleared of 
periadvential fat and were handled carefully to preserve an 
intact endothelium. The aortic rings (4-5 mm) were kept in 
warmed (37°C) and gas-equilibrated (95% O2, 5% CO2) 
Krebs solution containing: 1.6 mM CaCl2, 1.17 mm MgSO4, 
26 µM EDTA, 130 mM NaCl, 14.9 mM NaHCO3, 4.7 mM 
KCl, 1.18 mM KH2PO4, and 11 mM glucose. 
Vascular superoxide production
Lucigenin-amplified chemiluminescence assays. Each 
rat aorta segment was immersed in Krebs buffer at pH 
7.40, for 20 min. The arterial segments were then rapidly 
transferred to a counting vial under light protection and im-
mersed in a 5-µM lucigenin (Sigma, USA) solution in Krebs 
buffer (total volume = 1.0 mL). This lucigenin concentration 
is within the range proposed to be less likely to undergo 
redox cycling, reflecting, therefore, superoxide generation 
by tissues (5,6). The luminescence emitted by each frag-
ment was measured for 5 min in a Berthold Multi Biolumat 
luminometer (Berthold, Germany). Background signals from 
buffer and lucigenin were subtracted from artery signals 
and the resulting value was normalized for dry weight. 
Data are reported as counts per min (cpm) per mg of dry 
tissue. Chemiluminescence was measured directly and 
continuously for 5 min to obtain basal values. Superoxide 
generation from rat aortic ring segments was obtained 
under several experimental conditions. To analyze the role 
of specific pathways, some compounds were added at the 
following final concentrations: 1) 1 mM L-NAME, 2) 10 µM 
reactive blue, 3) 1 µM pyridoxalphosphate-6-azophenyl-
2’,4’-disulfonic acid (PPADS), 4) 0.1 mM 2-methylthioad-
enosine 5’-triphosphate (2MeSATP; a non-selective P2Y 
agonist), and 5) 30 µM β-γ-methylene-ATP (a partially 
selective P2X antagonist). After 5 min a new record of 
superoxide production was obtained. ATP was added at a 
final concentration of 0.1 mM, 10 min after addition of the 
compounds, and after 5 min a new record of superoxide 
production was obtained.
Vascular reactivity in isolated aortic rings
The thoracic aortas were mounted in organ baths filled 
with warm (37°C) and gas-equilibrated Krebs solution. 
Isometric tension was measured with isometric transduc-
ers (Biopac Systems, TSD105A, USA), digitized, stored, 
and displayed on a computer. The pre-load was 1.5 g and 
the solution was changed every 20 min within the first 
hour (22). A dose-response curve for ATP (10 nM to 100 
µM) was constructed after preconstriction with 0.1 µM 
norepinephrine. L-NAME was added to the bath solution 
to a final concentration of 1 mM and the aortic rings were 
pre-incubated for 15 min before the determination of the 
dose-response curve for ATP.
Nitrate content in the aorta
Harvested aortas were snap frozen in liquid nitrogen and 
then homogenized with a stainless steel mortar cooled in 
liquid nitrogen. Tissue dry powder was dissolved in Krebs 
solution and centrifuged at 1600 g for 5 min. The supernatant 
was then injected into the NO analyzer (Sievers Instrument, 
USA) for direct assessment of NO and metabolites. Nitrate 
content was normalized according to protein concentration 
in the extract and the amount of protein in tissue homoge-
nates was assayed by the method of Bradford.
iNOS identification and quantification in aorta
RNA was extracted from aorta tissue with Trizol® (Gibco-
BRL, USA) according to manufacturer instructions. RT-PCR 
was performed using ImProm-II Reverse Transcriptase 
(Promega, USA) with 1 µg of total RNA as a template 
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annealed with Oligo dT (Promega) for cDNA synthesis. 
This reaction was performed at 42°C for 50 min followed 
by 70°C for 15 min to inactivate the reverse transcriptase 
enzyme. For inducible NOS (iNOS) amplification, PCR was 
performed with 35 cycles of 94°C for 30 s, 92°C for 1 min, 
63.5°C for 1 min, and 72°C for 1 min followed by a final 
extension for 10 min at 72°C. The following primers were 
used to amplify 170 bp for rat iNOS (Gen Bank accession 
No. D44591) forward primer: 5’ CAC CTT GGA GTT CAC 
CCA GT 3’ and reverse primer: 5’ ACC ACT CGT ACT TGG 
GAT GC 3’. GAPDH was used as a housekeeping gene. 
The reactions were carried out in an MJ Research Thermal 
Cycler PTC 200 (USA). The products were electrophoresed 
on 1% agarose gel and visualized by ethidium bromide 
staining. Densitometry values were normalized to GAPDH 
expression using the ImageJ program and the quantity 
of mRNA was determined with the Genius Plus software 
(TECAN Austria GMBH, Austria). 
Identification of the phosphorylated proteins: 
Akt and eNOS
Pulverized vessels were rehydrated with lysis buffer 
containing 20 mM HEPES, 150 mM NaCl, 1.5 mM MgCl2, 
1.0 mM EGTA, 10% glycerol, 1% Triton, 1 µg/mL aproti-
nin, 1 µg/mL leupeptin, 1.0 mM PMSF and phosphatases 
inhibitors (2 mM sodium orthovanadate, 50 mM sodium 
fluoride, and 10 mM sodium pyrophosphate). Total protein 
concentration was determined with the Bio-Rad Protein As-
say (Bio-Rad, USA). After heating at 100°C for 5 min, 50 µg 
protein under reduced conditions (phospho-Akt and β-actin 
antibodies) and under non-reduced conditions (eNOS and 
phospho-eNOS antibodies) were resolved by SDS-PAGE 
on a 10% gel and transferred to a nitrocellulose membrane. 
The nitrocellulose membranes were incubated in blocking 
buffer (TBS with 5% milk and 0.05% Tween 20) for 2 h at 
room temperature and then probed with mouse anti-eNOS 
(1:1000, Calbiochem, USA), mouse anti-phospho-eNOS 
(1:1000, Calbiochem), rabbit anti-phospho-Akt antibody 
(1:500, Santa Cruz Biotech, USA), and mouse anti-β-actin 
(1:10,000, Sigma-Aldrich, USA) overnight at 4°C. The mem-
branes were then washed and incubated with horseradish 
peroxidase-conjugated goat anti-mouse IgG (1:2000 for 
eNOS, 1:2000 for phospho-eNOS, and 1:10,000 for β-actin; 
Calbiochem) or horseradish peroxidase-conjugated goat 
anti-rabbit IgG (1:1500 for phospho-Akt; Calbiochem). 
Proteins were visualized using the ECL Western Blotting 
Analysis System (GE Healthcare, USA).
Reagents
All chemicals were purchased from Sigma, except when 
otherwise stated.
Statistical analyses
Data are reported as means ± SEM in all figures. 
The Student t-test was used to compare two groups and 
ANOVA was used for three or more groups, followed by 
the Bonferroni post-test. The level of significance was set 
at P < 0.05.
Results
Endotoxemic aortic rings presented increased 
relaxation in response to ATP
Endothelium-dependent relaxation (acetylcholine) is 
impaired in endotoxemic animals (23). We first determined 
whether aortic rings from LPS animals presented differ-
ent relaxant responsiveness to ATP compared to control. 
There was a greater relaxation response to ATP in LPS 
animals vs control (106.72 ± 2.29 vs 100.15 ± 0.85%; P < 
0.05; Figure 1). 
ATP vasorelaxation is mediated by NOS
We used L-NAME (1 mM) in vitro during vascular re-
activity procedures to determine the role of vascular NO 
production by ATP (10 nM to 100 µM). L-NAME inhibits NOS 
and is a useful tool employed to analyze if vasorelaxation 
is NO related. L-NAME almost completely blocked the re-
laxation response to ATP (Figure 2A,B) in the aortas from 
both control and LPS-treated animals. 
ATP decreases NOS superoxide production in sepsis
There was a significant increase of superoxide in aorta 
from LPS animals vs control (9424.6 ± 1098.9 vs 1212 ± 
127.3 counts/mg aorta). ATP reduced superoxide release 
to 4769.7 ± 797.9 counts/mg dry aorta tissue in LPS-treated 
animals (P < 0.05; Figure 3).
NOS-dependent superoxide production was analyzed 
using the NOS inhibitor L-NAME, which reduced superoxide 
Figure 1. Rat vascular ring reactivity. Thoracic aortas were har-
vested 16 h after lipopolysaccharide (LPS) or saline adminis-
tration and their relaxation in response to ATP was measured. 
Data are reported as means ± SEM for each experimental group 
containing 6 rats. A significant increase in maximal relaxation in 
response to ATP occurred in LPS-treated animals compared to 
control (*P < 0.05, Student t-test).
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production by LPS aortic rings: 13,277 ± 695 counts/mg 
aorta for LPS vs 6614 ± 640 counts/mg aorta for LPS-L-
NAME (P < 0.05; Figure 4). The superoxide release-reducing 
effect of ATP was completely blocked by L-NAME: 6614 ± 
640 counts/mg aorta for LPS-L-NAME vs 6753 ± 525 counts/
mg aorta for LPS-L-NAME-ATP (P > 0.05; Figure 4). 
A direct measurement of nitrate and iNOS in aortic rings 
was also conducted. The aortic rings taken from LPS animals 
showed a significantly higher peak of nitrate content (17.4 
± 3.5 vs 5.25 ± 0.4 µM/mg protein for LPS vs control; P < 
0.05; Figure 5A). iNOS expression analyzed by RT-PCR 
was also increased in LPS animals (Figure 5B).
The effect of ATP is mediated via P2Y
P2X and P2Y inhibitors were added to the bath solution 
and only the reactive blue P2Y inhibitor blocked the effect of 
ATP in reducing superoxide production (4129 ± 601 vs 3797 ± 
946; P > 0.05; Figure 6), while the P2X inhibitor PPADS did not 
block the action of ATP (6078 ± 822 vs 3361 ± 438; P < 0.05; 
Figure 6). Different agonists were used to check and confirm 
the purinergic receptor. When 2MeSATP (a non-selective P2Y 
agonist) and β-γ-methylene ATP (partially selective P2X) were 
Figure 2. The role of nitric oxide in ATP relaxation of vascular rings. Thoracic aortas were harvested 16 h after saline (A) or lipopoly-
saccharide (LPS; B) administration to measure relaxation in response to ATP with or without L-NAME (1 mM). Data are reported as 
means ± SEM for each experimental group containing 6 rats. A significant decrease of relaxation occurred with L-NAME (*P < 0.05, 
Student t-test).
Figure 3. Effect of lipopolysaccharide (LPS) and ATP on super-
oxide production by aortic rings incubated ex vivo. Thoracic aortic 
rings were harvested from control rats or from experimental rats 
16 h after LPS administration to measure superoxide production. 
ATP was added to the bath solution during incubation in order to 
obtain a 5-µM final concentration. Data are reported as means ± 
SEM for each experimental group containing 9 rats. +P < 0.05 for 
basal control vs basal LPS: a significant increase of superoxide 
production occurred compared to control animals; *P < 0.05 for 
basal LPS vs LPS plus ATP: a significant direct action of ATP re-
ducing superoxide production in LPS-treated animals compared 
to baseline (ANOVA and Bonferroni’s test). 
Figure 4. Effect of L-NAME on superoxide production by aorta 
incubated ex vivo. Thoracic aortic rings were harvested from rats 
16 h after lipopolysaccharide (LPS) administration to measure 
superoxide production. Superoxide production was measured 
in the same aortic ring sequentially under three conditions: 1) 
basal; 2) L-NAME addition (1 mM); 3) followed by ATP addition 
(0.1 mM). Data are reported as means ± SEM for each experi-
mental group containing 9 rats. *P < 0.05, significant decrease of 
superoxide production compared to basal LPS (ANOVA and Bon-
ferroni’s test). There was no decrease in superoxide production 
when LPS L-NAME was compared to LPS L-NAME plus ATP. 
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incubated with aortic rings, only 2MeSATP reduced super-
oxide production (5537 ± 821 vs 4905 ± 946; P < 0.05), 
whereas β-γ-methylene ATP did not modify superoxide 
production (5402 ± 911 vs 5491 ± 735; Figure 6).
ATP increases aortic content of the phosphorylated 
proteins: Akt (p-Akt) and eNOS (p-eNOS)
The addition of ATP to the bath solution containing the aor-
tic rings produced a transient increase in p-Akt (Figure 7A,B) 
Figure 5. Nitric oxide production after lipopolysaccharide (LPS) administration. A, Nitrate concentration in aortic rings. There was a 
significant increase of nitrate content in the aorta after LPS administration. B, RT-PCR for inducible nitric oxide synthase (iNOS) ex-
pression in aortic rings. Data are reported as means ± SEM for each experimental group containing 6 rats. GAPDH = glyceraldehyde-
3-phosphate dehydrogenase. There was an increased expression of iNOS after LPS injection compared with control animals. *P < 0.05 
for control vs LPS (Student t-test).
Figure 6. Effect of ATP, ATP agonists and inhibitors on superoxide production by aorta incubated ex vivo. Thoracic aortic rings were 
harvested from rats 16 h after LPS administration to measure superoxide production. The aorta was initially incubated without any 
compound to obtain a basal value (white columns). After 10 min, one of the following compounds was added: ATP (1 mM), 2MeSATP 
(0.1 mM - a nonselective agonist) or methylene-ATP (30 µM - a partially selective P2X). The inhibitors PPADS (1 µM) or RB (10 µM) 
were added to two sets of aortic rings to which ATP had been previously added. RB = reactive blue; PPADS = pyridoxalphosphate-6-
azophenyl-2’,4’-disulfonic acid; 2MeSATP = 2-methylthioadenosine 5’-triphosphate. Data are reported as means ± SEM for experimen-
tal group containing 9 rats. *P < 0.05, significant decrease of superoxide production compared to basal LPS (Student t-test).
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lasting 3 min and returning to basal levels thereafter. 
The increase in p-Akt was more intense in the LPS aorta 
group than in the control (Figure 7B). The presence of 
ATP induced an increase in the amount of p-eNOS in both 
the control and LPS groups (Figure 7A,C). The amount of 
total eNOS was lower in the LPS group than in the control 
group (Figure 7C).
Discussion
Sepsis is a well-known condition presenting an 
endothelium-dependent reduced vasorelaxation. Ex vivo 
experiments have demonstrated the loss of endothelial 
function in LPS-treated animals, as measured by the re-
laxant responsiveness of pre-contracted vascular rings to 
the endothelium-dependent vasodilator NO liberating the 
hormone acetylcholine. ATP is also known to induce NO 
synthesis and release; however, there are no studies of the 
vascular relaxant responsiveness to ATP of septic animals 
(10-13). The average concentration of nucleotides in plasma 
and in other extracellular fluids is generally in the 0.4- to 
6-µM range (24), and these values can increase at sites of 
vascular inflammation, ischemia and platelet degranulation 
(25). Our data confirm that ATP produces vasorelaxation 
through NO release. Figure 2 shows that L-NAME inhibited 
aorta relaxation induced by ATP in both control and LPS 
animals. ATP induced greater relaxation compared to con-
trol a result that is opposite to the effect of acetylcholine 
(23) detected in endotoxemic animals. The effect of ATP in 
increasing vascular caliber improves the matching between 
oxygen supply and metabolic demand (26).
In the present stud, the increased superoxide produc-
tion in the aorta was followed by increased aortic nitrate 
content, iNOS mRNA expression, and increased amounts 
of nitrotyrosine in the aorta (data not shown). In various 
disease conditions, all types of NOS (neuronal, inducible, 
and endothelial) have been reported to generate oxidants 
through unknown mechanisms (27,28). The catalytic activity 
of eNOS is exquisitely sensitive to ONOO–, which decreases 
NO synthesis and increases superoxide anion (O2•–) pro-
duction by the enzyme (29). Hence, eNOS exposure to 
oxidants including ONOO– causes increased enzymatic 
uncoupling and generation of O2•–, further contributing to 
oxidant stress in endothelial cells (29). In the LPS group, 
ATP not only increased vasorelaxation (Figure 1) but sig-
nificantly decreased superoxide production (Figure 3). The 
reduction in superoxide production by ATP may explain the 
better vasorelaxation performance of septic aortic rings. 
Figure 7. Phosphorylated proteins in a pool of 3 aortae after ATP incubation. A, Western blots of endothelial nitric oxide synthase 
(eNOS), β-actin and phosphorylated proteins (p-eNOS and p-Akt). The images are from control, control plus ATP incubation (3 and 9 
min), septic aorta, and septic aorta plus ATP incubation (3 and 9 min). B, p-Akt quantification of the Western blot data. The presence 
of ATP in the bath produced a transient increase in p-Akt of the septic aorta. C, p-eNOS to eNOS ratio of the Western blot data. The 
addition of ATP induced an increase of p-eNOS in the aorta of all animals. LPS = lipopolysaccharide. All assays were performed with 
3 pooled aortae.
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In addition, we showed that L-NAME also reduced super-
oxide production, in agreement with literature reports that 
superoxide production by uncoupled NOS was blocked by 
L-NAME but not by apocynin (an NADPH oxidase inhibitor) 
(4,30). Next we checked the effect of ATP in the presence of 
L-NAME and we observed that the inhibitory effect of ATP 
on superoxide production was blocked by L-NAME. These 
data suggest that NOS activity was an important source 
of superoxide in the present study. In addition, the data 
suggest that the purinergic effect on superoxide production 
is related to the regulation of NOS activity. Therefore, the 
presence of ATP seems to reverse superoxide production by 
NOS and the NO release induced in septic aortas. Assays 
using different antagonists and agonists have confirmed 
that this effect is produced by purinergic activation. The 
action of ATP on superoxide production is due to the P2Y 
receptor, as confirmed by the experiments using agonists 
and antagonists the P2Y and P2X receptors. The P2Y re-
ceptors in endothelial cells (P2Y1, P2Y2, and P2Y11) are 
G protein-linked and activate the phosphoinositol system, 
leading to store-operated calcium influx after inositol (1,4,5) 
P3-induced release of calcium from intracellular stores and, 
in the case of P2Y11, are also linked to the cAMP/protein 
kinase A pathway.
We found a maximal increase in NO and O2•– produc-
tion in the aorta 16 h after LPS administration, just when 
the vascular relaxation to acetylcholine was compromised 
(data not shown). Superoxide is an NO scavenger and 
rapidly reacts to form peroxynitrite (ONOO–) (31). eNOS 
uncoupling, whereby eNOS generates O2•– rather than NO, 
is an important mechanism underlying endothelial dysfunc-
tion (4). Endothelial dysfunction in sepsis is associated 
with reduced NO bioactivity and increased O2•– production 
(4). Various studies have also shown that NOS may suf-
fer oxidation during situations of intense oxidative stress, 
and this leads NOS to produce superoxide instead of NO 
(28,29,32). Another explanation for this uncoupling is the 
oxidation of tetrahydrobiopterin, a critical cofactor for the 
NO synthases. When tetrahydrobiopterin is absent these 
enzymes become “uncoupled” (28,33). The production of 
reactive oxygen species (ROS) in blood vessels occurs 
from two main sources. An NADPH oxidase, similar to the 
neutrophil oxidase, is present in endothelial and vascular 
smooth muscle cells and seems to be a source of ROS (13). 
In addition, the endothelial and neuronal NOS (eNOS and 
nNOS, respectively), both cytochrome p450 reductase-like 
enzymes (14), can produce large amounts of ROS when 
deprived of their critical cofactor tetrahydrobiopterin or their 
substrate L-arginine (15-22). 
Stimulation of astrocytic P2X7 receptors, as well as 
other P2 receptors, has been shown to induce Akt activation 
(34). Extracellular ATP acting in part through Gi proteins 
increased PI3K activity in a time-dependent manner and a 
transient phosphorylation of Akt was produced (35). West-
ern blotting measurements showed that p-Akt and p-eNOS 
were induced by ATP (Figure 7). The increase in the aorta 
content of p-eNOS occurred in both control and LPS animals. 
Although septic aortic rings showed a reduced amount of 
eNOS, ATP addition was effective in increasing the amount 
of p-eNOS. The eNOS enzyme has been shown to present 
higher activity when phosphorylated (36,37). In the present 
experiments, ATP increased p-eNOS while simultaneously 
reducing superoxide production. The superoxide production 
through NOS activity was confirmed in the experiments using 
L-NAME, an NOS inhibitor. Literature data regarding differ-
ent cell lines have shown that Akt directly phosphorylates 
eNOS (4). In order to check this pathway, in our study we 
showed that p-Akt was increased within a very short time 
after ATP stimulation. Akt may participate in the pathway 
inducing eNOS phosphorylation by ATP in LPS animals. A 
limitation of our study is that we did not check the effect 
of an Akt inhibitor on superoxide production and p-eNOS 
amount in order to confirm this pathway as determinant of 
the effects. 
Normal vascular reactivity is a crucial factor in main-
taining adequate blood perfusion. Septic vessels present 
severe functional impairment, which is associated with 
end-organ damage (38). ATP is an endogenous substance 
eliciting endothelium-dependent vascular relaxation. Even 
in the presence of endothelial dysfunction ATP produces 
effective vascular relaxation. Through the property shown 
in the present study of reducing superoxide production 
and increasing or maintaining NO release in conditions of 
endothelial damage, ATP is able to sustain better vascular 
reactivity. These findings suggest a novel role for ATP in 
the endothelium under oxidative stress, i.e., the induction 
of eNOS phosphorylation that “recouples” NOS activity 
with a consequent reduction in superoxide production and 
with the occurrence of appropriate vasorelaxation. The 
development of compounds and drugs with an action based 
on purinergic activation would be highly desirable for the 
treatment of septic endothelial dysfunction. 
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